Title of article
Azithromycin-Related Bicytopenia: An Exceptional Adverse Effect
Author/Authors
Hammami ، Fatma Infectious Diseases Department - Hedi Chaker University Hospital - University of Sfax , Fourati ، Salma Infectious Diseases Department - Hedi Chaker University Hospital - University of Sfax , Koubaa ، Makram Infectious Diseases Department - Hedi Chaker University Hospital - University of Sfax , Smaoui ، Fatma Infectious Diseases Department - Hedi Chaker University Hospital - University of Sfax , Rekik ، Khaoula Infectious Diseases Department - Hedi Chaker University Hospital - University of Sfax , Marrakchi ، Chakib Infectious Diseases Department - Hedi Chaker University Hospital - University of Sfax , Ben Jemaa ، Mounir Infectious Diseases Department - Hedi Chaker University Hospital - University of Sfax
Pages
2
From page
118
To page
119
Abstract
Macrolide antibiotics are commonly prescribed and are usually well tolerated. Azithromycin-related anemia and thrombocytopenia has not been reported previously. Here, we present the case of a 63-year-old man with bicytopenia following azithromycin treatment for ocular toxoplasmosis. He developed both thrombocytopenia and anemia after less than 7 days of treatment. Pyrimethamine, known for its hematologic side effects, was stopped on admission. However, the platelets drop continued to worsen. Then, azithromycin has been incriminated. All his symptoms and laboratory abnormalities were recovered within 7 days after the discontinuation of azithromycin treatment. Physicians must be aware of azithromycin-induced bicytopenia because its early detection can decrease the severity of these side effects.
Keywords
Azithromycin , Anemia , Adverse Effect , Thrombocytopenia
Journal title
Journal of Pharmaceutical Care
Record number
2494550
Link To Document